Skip to Content
scroll

James Hardie (ASX: JHX) $39.20

JHX -6.22%: Reported a softer-than-expected 2Q27 result, with net sales missing consensus and its 3Q27 forecast coming in below market expectations. Despite continued growth in North America and Australia & New Zealand, the near-term outlook remains challenging.

Key details:

  • 2Q net sales of US$1.43bn, below the US$1.45bn consensus.
  • Adjusted earnings (EBITDA) of US$454.7m and adjusted net income of US$248.5m.
  • 3Q sales guidance of US$1.06–1.14bn, below the US$1.2bn consensus.
  • North American fiber cement and Deck, Rail & Accessories delivered double-digit growth.
  • Australia & New Zealand continued to benefit from market share gains.
  • FY27 sales and EBITDA outlook reaffirmed, with free cash flow target increased.

 MM’s view: The weaker third-quarter outlook is disappointing and points to near-term softness, despite positive underlying performance in North America and Australia & New Zealand. Management reaffirmed FY27 guidance and increased the free cash flow target which provide some reassurance, though the focus is now on whether the company can improve the second-half picture and beat rather than just meet the full-year earnings forecasts.

JHX
MM is neutral towards JHX
Add To Hit List
chart
image description
James Hardie (JHX)
image description

Relevant suggested news and content from the site

Back to top